Extended maintenance intervals for implanted venous ports in oncology: A retrospective assessment of 24-week intervals (PORT-24 study)

A 24-week TIVAP maintenance interval after completion of intravenous therapy appeared feasible and safe in this real-world cohort, with no infections and excellent port survival. These findings support cautious consideration of ultra-extended intervals in selected cancer survivors but require confirmation in larger prospective comparative studies before broad implementation.Categories:Supportive oncology, vascular access, health services and survivorship care.